Shanghai Junshi Biosciences Co Ltd

Shanghai Junshi Biosciences Co Ltd is a leading biotechnology company dedicated to the discovery, development, and commercialization of innovative drugs on a global scale. With a focus on providing patients with superior and cost-effective treatment options, Junshi Biosciences stands at the forefront of macromolecular drug research and development, leveraging its core protein engineering platform technology.

Junshi Biosciences excels in innovative drug discovery, advanced biotechnological R&D, and large-scale production across the entire industry chain. The company’s rapidly expanding drug candidate portfolio demonstrates tremendous market potential, positioning Junshi BioPharma as a leader in immuno-oncology and the treatment of autoimmune and metabolic diseases. Shanghai Junshi Biosciences Co Ltd's primary address is 15F, Building 7, No.6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai, 200126, CN, with additional locations at 9430 Key West Ave, Suite 125, Rockville, Maryland 20850, US; 1440 OBrien Dr, Suite A1, Menlo Park, California 94025, US; No.1069 Xinyang Road, Lin-Gang Special Area, China (Shanghai) Pilot Free Trade Zone, Shanghai, 201306, CN; No. 8 Pangyang Road, Wujiang District, Suzhou, Jiangsu 215200 , CN; and No. 999 Longqiao Road, Wujiang District, Suzhou, Jiangsu 215200, CN.

Shanghai Junshi Biosciences Co Ltd is committed to translational medicine, aiming to develop first-in-class and best-in-class drugs through original innovation. By enriching its product pipelines and exploring drug combination therapies, Junshi BioPharma is expanding its innovation to include small molecule drugs and antibody-drug conjugates (ADCs), as well as next-generation innovative therapies for cancer and autoimmune diseases. We invite the manager of Shanghai Junshi Biosciences Co Ltd to create a customized and exclusive company showcase and product listing on our platform.